| Literature DB >> 35990176 |
Ahmad S Naja1, Nour Bouji2, Mohamad Nasser Eddine3, Humaid Alfarii3, Rudolf Reindl3, Yehia Tfayli1, Mohamad Issa1, Said Saghieh1.
Abstract
Aim: This article aims to compare the outcomes between open reduction and internal fixation (ORIF) and external fixation (ExFix) in tibial plateau fractures. Background: Open reduction and internal fixation and external fixation are common methods for managing tibial plateau fractures without a consensus of choice. Materials and methods: PubMed, Cochrane Library, Ovid, CINAHL®, Scopus, and Embase were searched. Clinical studies in humans comparing ExFix and ORIF for tibial plateau fractures were included. Case reports, pathological, and biomechanical studies were excluded. Two investigators reviewed the studies independently, and any discrepancies were resolved. The quality and heterogeneity of each study were assessed in addition to calculating the odds ratio (OR) of the surgical outcomes and complications at a 95% confidence interval, with p <0.05 as statistical significance.Entities:
Keywords: External fixator; Fracture; Internal fracture fixation; Tibia
Year: 2022 PMID: 35990176 PMCID: PMC9357793 DOI: 10.5005/jp-journals-10080-1557
Source DB: PubMed Journal: Strategies Trauma Limb Reconstr ISSN: 1828-8928
Quality assessment for non-randomised trials (MINORs)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| A clearly stated aim | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 |
| Inclusion of consecutive patients | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 |
| Prospective data collection | 0 | 2 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 2 | 0 | 0 |
| Endpoints appropriate to the aim of the study | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 |
| Unbiased assessment of the study endpoint | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 |
| Follow-up period appropriate to study aims | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 |
| Less than 5% loss to follow-up | 1 | 2 | 0 | 2 | 0 | 2 | 2 | 2 | 2 | 1 | 2 | 2 | 2 |
| Prospective sample size calculation | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| An adequate control group | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 |
| Contemporary groups | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 |
| Baseline equivalence of groups | 2 | 2 | 2 | 1 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 1 | 2 |
| Adequate statistical analyses | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 |
| Total score | 19 | 22 | 18 | 19 | 20 | 20 | 20 | 20 | 20 | 19 | 22 | 20 | 20 |
Risk of Bias 2 (RoB 2) for randomised controlled trials
|
|
|
|---|---|
| Bias arising from the randomisation process | Low risk |
| Bias due to deviations from intended interventions | Low risk |
| Bias due to missing outcome data | Low risk |
| Bias is measurement of the outcome | High risk |
| Bias in selection of the reported result | Some concerns risk |
Flowchart 1PRISMA flow diagram showing the study selection process
Characteristics of included studies
|
|
|
|
|
|
| |
|---|---|---|---|---|---|---|
|
|
| |||||
| Ahearn et al.[ | Retrospective, Non-RCT | 44 years | [ | TSF (21) | Lateral locking plate ± medical plate fixation (34) | ExFix: 31 months |
| Bertrand et al.[ | Retrospective, Non-RCT | 46.71 years | [ | Hybrid external fixator (67) | Two buttressing plates (26) | 24 months |
| Berven et al.[ | Retrospective, Non-RCT | ExFix: 55.74 years | [ | Ilizarov wire frame (62) | Locking plates (68) | 6 months |
| Boston | Retrospective, Non-RCT | 45 years | NM | Monticelli-Spinelli circular fixator (10) | Bilateral buttress, semi-tubular plates, or cannulated screws (7) | ExFix: 10 months |
| Bove et al.[ | Retrospective, Non-RCT | ExFix: 51 years | [ | Ilizarov frame (1/14 7.14%), TrueLok (2/14 14.2%), Ring Rod (2/14 14.2%), TSF (9/14 64.2%) (14) | LISS (14) | 12 months |
| Chan et al.[ | Retrospective, Non-RCT | ExFix: 52.03 years | [ | Ilizarov circular frame (23/35, 65.7%), Hoffman II with limited internal fixation (13/35, 37.1%) (35) | Buttress plate (21/24, 84%), LISS (4/24, 16%) (24) | 3, 6, 12, and 24 months |
| Chertsey | Retrospective, Non-RCT | NM | [ | Ilizarov circular frame (79) | NM (45) | NM |
| Conserva et al.[ | Retrospective, Non-RCT | 54.1 years | [ | Percutaneous lag screw + hybrid external fixator (41) | LCP ± bone graft substitute (38) | EF: 39.4 months |
| COTS[ | RCT | ExFix: 46.2 years | [ | Percutaneous lag screw, and Ilizarov circular frame (43) | Medial and lateral non-locking buttress plates ± bone grafting (40) | 6,12, 24 months |
| Jansen et al.[ | Retrospective, Non-RCT | 46 years | [ | Ilizarov circular frame (2) | LISS (19/20, 95.0%) ± additional plates (7/20, 30.4%) ± artificial bone substitute (7/20, 30.4%) (21) | 67 months |
| Krupp et al.[ | Retrospective, Non-RCT | ExFix: 48.8 years | [ | Hoffman II Hybrid (16/28, 57.1%) or circular frames (14/28, 50.0%) (30) | Dual platting (8/28, 28.6%), Lateral locking plate + medial screws or buttress plate (20/28, 71.4%) (28) | EF: 16.4 months |
| Malakasi et al.[ | Prospective, Non-RCT | 40.5 years | [ | Hybrid external fixator (30) | Antiglide plates or cannulated screws (30) | 12 months |
| Pun et al.[ | Retrospective, Non-RCT | 43.85 years | [ | Circular frame + medial percutaneous screws (12) | Dual plate (9) | 30 months |
| Zhuo et al.[ | Retrospective, Non-RCT | ExFix: 44.2 years | [ | Hybrid external fixator (27) | Screws, steel plates (39) | 1–5 years |
COTS, Canadian Orthopaedic Trauma Society; ExFix, external fixation; LCP, locking compression plate; LISS, less invasive stabilisation system; NM, not mentioned; Non-RCT, non-randomised control trial; ORIF, open reduction and internal fixation; RCT, randomised control trial; TSF, Taylor spatial frame;
amulticentre randomised controlled trial;
borthopaedic trauma association classification;
cSchatzker classification;
dthe chertsey classification of tibial plateau fractures
Overall effect and heterogeneity of postoperative outcomes and complications
|
|
|
|
|
|
|
|---|---|---|---|---|---|
| Malunion | 2 | 1.54 (0.62–3.78) | <0.01 | 87% | 0.35 |
| Non-union | 3 | 0.60 (0.24–1.52) | 0.42 | 0% | 0.28 |
| Postoperative osteoarthritis (PTOA) | 7 | 1.67 (1.08–2.58) | 0.65 | 0% | 0.02 |
| Reoperation | 6 | 1.03 (0.65–1.65) | 0.37 | 7% | 0.89 |
| Total knee replacement | 5 | 0.51 (0.20–1.34) | 0.99 | 0% | 0.17 |
| Superficial infections | 13 | 3.40 (2.03–5.68) | 0.04 | 45% | <0.01 |
| Deep infections | 8 | 1.14 (0.60–2.17) | 0.20 | 29% | 0.70 |
| Deep vein thrombosis | 4 | 1.67 (0.59–4.74) | 0.26 | 25% | 0.33 |
| Compartment syndrome | 2 | 0.61 (0.12–3.20) | 0.37 | 0% | 0.56 |
| Heterotopic ossification | 2 | 0.17 (0.04–0.80) | 0.38 | 0% | 0.03 |
| Knee stiffness | 4 | 1.38 (0.62–3.03) | 0.36 | 6% | 0.43 |
| Flexion <90° | 2 | 3.71 (0.78–17.59) | 0.90 | 0% | 0.10 |
| Extension deficit ≥10° | 2 | 1.17 (0.56–2.42) | 0.39 | 0% | 0.68 |
Fig. 2Malunion and non-union odds ratios
Fig. 3Postop osteoarthritis (PTOA) odds ratios
Fig. 4The odds ratios of reoperation and total knee replacements (TKR)
Fig. 5Superficial and deep infection odds ratios
Fig. 6The odds ratios of postoperative deep vein thromboembolism and compartment syndrome
Fig. 7Heterotopic ossifications odds ratio
Fig. 8The odds ratios of function parameters: Knee stiffness, extension deficit of ≥10°, and flexion <90°